St George Mining Limited (ASX:SGQ) Starts Major Drilling at Araxá Project
St George Mining (ASX:SGQ) launches a 10,000m drilling campaign at the Araxá Project in Brazil to expand rare earth and niobium resources.
Johns Lyng Group (ASX:JLG) Receives Indicative Offer from PEP
Johns Lyng Group (ASX:JLG) receives a non-binding offer from Pacific Equity Partners to acquire 100% of the company.
Ventia Services Group (ASX:VNT) Awarded $800M Fibre Upgrade Contract with NBN Co
Ventia Services Group (ASX:VNT) secures $800M contract with NBN Co to enhance Australia’s fibre network.
Articore Group Limited (ASX:ATG) Reaffirms FY25 Guidance and Announces Strategic Review
Articore Group Limited (ASX:ATG) reaffirms its FY25 guidance and initiates a strategic review to enhance shareholder value and accelerate growth.
Cokal Limited (ASX:CKA) Secures US$15 Million Debt Funding
Cokal Limited (ASX:CKA) secures US$15 million in strategic debt funding to boost metallurgical coal production and ends agreements with Cratus.
GenusPlus Group Ltd (ASX:GNP) Secures $130 Million NBN Contract
GenusPlus Group Ltd (ASX:GNP) secures a $130 million contract with NBN Co to upgrade fiber infrastructure across Western Australia.
PYC Therapeutics (ASX:PYC) Receives Approval for Dose Escalation in ADOA Clinical Trial
PYC Therapeutics (ASX:PYC) receives approval to escalate dosing in its ADOA clinical trial, advancing development of its PYC-001 drug candidate.
4DMedical Limited (ASX:4DX) Partners with Olympus to Launch SeleCT™ Screening Campaign
4DMedical Limited (ASX:4DX) partners with Olympus to deploy AI-powered SeleCT™ Screening, enhancing COPD diagnosis and treatment.
Siren Gold Limited (ASX:SNG) Announces High-Grade Antimony-Gold Update at Langdons
Siren Gold Limited (ASX:SNG) reports significant gold and antimony grades from its Langdons project, highlighting exploration progress and next steps.
Radiopharm Theranostics (ASX:RAD) Receives FDA Fast Track for RAD101
Radiopharm Theranostics (ASX:RAD) secures FDA Fast Track for RAD101, advancing its Phase 2 trial in brain metastases imaging.